U.S. markets closed
  • S&P Futures

    3,895.00
    -8.75 (-0.22%)
     
  • Dow Futures

    31,364.00
    -57.00 (-0.18%)
     
  • Nasdaq Futures

    12,010.50
    -30.00 (-0.25%)
     
  • Russell 2000 Futures

    1,767.40
    -2.40 (-0.14%)
     
  • Crude Oil

    110.70
    +1.13 (+1.03%)
     
  • Gold

    1,824.10
    -0.70 (-0.04%)
     
  • Silver

    21.06
    -0.11 (-0.53%)
     
  • EUR/USD

    1.0578
    -0.0009 (-0.08%)
     
  • 10-Yr Bond

    3.1940
    +0.0690 (+2.21%)
     
  • Vix

    26.95
    -0.28 (-1.03%)
     
  • GBP/USD

    1.2265
    -0.0006 (-0.05%)
     
  • USD/JPY

    135.2400
    -0.2060 (-0.15%)
     
  • BTC-USD

    20,608.02
    -461.14 (-2.19%)
     
  • CMC Crypto 200

    447.53
    -14.26 (-3.09%)
     
  • FTSE 100

    7,258.32
    +49.51 (+0.69%)
     
  • Nikkei 225

    26,870.78
    -0.49 (-0.00%)
     

FDA authorizes Labcorp's direct-to-consumer test for RSV, the flu, and COVID-19

·1 min read
FDA authorizes Labcorp's direct-to-consumer test for RSV, the flu, and COVID-19
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

The Food and Drug Administration on Monday authorized a test developed by Laboratory Corporation of America Holdings that allows people in the U.S. to self-test for respiratory syncytial virus (RSV), a type of common cold, as well as the flu and COVID-19. The test does not require a prescription. People swab at home and send the test by mail to a Labcorp lab. Results are then made available in an online portal. Teens and children are also authorized to test with the support of adults. Labcorp's